Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aposense Ltd.
DescriptionApoptosis Targeted Therapy (ATT) composed of an Aposense probe conjugated with SN-38, the active metabolite of irinotecan
Molecular Target Topoisomerase I (TOP1)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today